alexa Treatment Of Disseminated Breast Cancer With Multiple Affection Nidi | 7199
ISSN: 2161-0665

Pediatrics & Therapeutics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Treatment of disseminated breast cancer with multiple affection nidi

International Conference on Pediatrics & Gynecology

G. A. Khakimov, B. B. Negmajanov and F. I. Zokirov

Accepted Abstracts-2011: Pediatr Therapeut

DOI: 10.4172/2161-0665.S1.06

Breast cancer (BC) is the most common cause of cancer ? related mortality in women. Th e main cause of mortality in this group is generalization of BC with development of polyorganic insuffi ciency in the background of chronic pain syndrome. In this connection the choice of rational methods of palliative therapy remains actual, especially in cases with multiple aff ection nidi. Objective of the study was to evaluate the volume of palliative chemoradiation therapy implamantation to increase the survival rate of patients. To research were included 23 women with disseminated breast cancer (DBC) at the age of 34-60 years and they were divided into 2 groups: Th e 1 st group consisted of 13 women with distant metastases in liver, bones of skeleton and skin. Th e 2 nd group consisted of 10 women with metastases in supraclavicular lymph nodes of aff ected site, in liver and bones of skeleton. Patients of fi rst group in the background of palliative polychemotherapy (PPCT) (4-6 cycles) ? taxanes with anthracyclines, received shortfocal therapy in the region of intradermal metastases. Patients of second group received similar PPCT with palliative radiation therapy in supraclavicular region ? 40-44 Gy. Patients of both group under control of blood Calcium levels received bisphosphonates. In patients with DBC in both of group average time for disease progression as development of polyorganic insuffi ciency with sharp limitation of specialized therapy arsenal was 8.7 months. In addition to that local disease control ? without signs of lymphostasis and limitations in volume of movement in upper extremity of aff ected site without impairment of patient?s life quality was marked. Implementation of palliative chemoradiation and X-ray therapy in patients with DBC allows to increase average time of disease progression and life quality of fatally diseased patients with DBC.
Khakimov Golib Abdullayevich: MD, Professor. Head of Department of Oncology in Tashkent Pediatric Medical Institute. Has publis hed more than 100 papers in reputed journals.
Leave Your Message 24x7